The impact of specific oxidized amino acids on protein turnover in J774 cells.

Oxidized protein deposition and accumulation have been implicated in the aetiology of a wide variety of age-related pathologies. Protein oxidation in vivo commonly results in the in situ modification of amino acid side chains, generating new oxidized amino acid residues in proteins. We have demonstrated previously that certain oxidized amino acids can be (mis)incorporated into cell proteins in vitro via protein synthesis. In the present study, we show that incorporation of o- and m-tyrosine resulted in increased protein catabolism, whereas dopa incorporation generated proteins that were inefficiently degraded by cells. Incorporation of higher levels of L-dopa into proteins resulted in an increase in the activity of lysosomal cathepsins, increased autofluorescence and the generation of high-molecular-mass SDS-stable complexes, indicative of protein aggregation. These effects were due to proteins containing incorporated L-dopa, since they were not seen with the stereoisomer D-dopa, which enters the cell and generates the same reactive species as L-dopa, but cannot be incorporated into proteins. The present study highlights how the nature of the oxidative modification to the protein can determine the efficiency of its removal from the cell by proteolysis. Protection against the generation of dopa and other species that promote resistance to proteolysis might prove to be critical in preventing toxicity from oxidative stress in pathologies associated with protein deposition, such as atherosclerosis, Alzheimer's disease and Parkinson's disease.

[1]  K. Uchida,et al.  Metal-catalyzed oxidation of protein-bound dopamine. , 2006, Biochemistry.

[2]  R. Dean,et al.  Evidence for L‐dopa incorporation into cell proteins in patients treated with levodopa , 2006, Journal of neurochemistry.

[3]  C. Karakukcu,et al.  Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis , 2006, Cell biochemistry and function.

[4]  Barry Halliwell,et al.  Oxidative stress and neurodegeneration: where are we now? , 2006, Journal of neurochemistry.

[5]  Jens Dreyhaupt,et al.  Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. , 2006, Investigative ophthalmology & visual science.

[6]  T. Siddique,et al.  Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Bigio,et al.  Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Z. Guo,et al.  Advanced Oxidation Protein Products Accelerate Atherosclerosis Through Promoting Oxidative Stress and Inflammation , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[9]  S. Pennathur,et al.  Misincorporation of free m-tyrosine into cellular proteins: a potential cytotoxic mechanism for oxidized amino acids. , 2006, The Biochemical journal.

[10]  D. Pearce,et al.  You say lipofuscin, we say ceroid: Defining autofluorescent storage material , 2006, Neurobiology of Aging.

[11]  A. Ciechanover Intracellular Protein Degradation: From a Vague Idea Thru the Lysosome and the Ubiquitin-Proteasome System and onto Human Diseases and Drug Targeting* * , 2006, Cell death and differentiation.

[12]  R. Dean,et al.  Translational incorporation of L‐3,4‐dihydroxyphenylalanine into proteins , 2005, The FEBS journal.

[13]  I. Wittmann,et al.  Accumulation of the hydroxyl free radical markers meta-, ortho-tyrosine and DOPA in cataractous lenses is accompanied by a lower protein and phenylalanine content of the water-soluble phase , 2005, Free radical research.

[14]  A. Goldberg,et al.  Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates. , 2005, Methods in enzymology.

[15]  E. Kominami,et al.  Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged , 2005, Virchows Archiv A.

[16]  R. Dean,et al.  Biosynthesis and turnover of DOPA-containing proteins by human cells. , 2004, Free radical biology & medicine.

[17]  M. Ruberg,et al.  Differential gene expression induced by chronic levodopa treatment in the striatum of rats with lesions of the nigrostriatal system , 2004, Journal of neurochemistry.

[18]  E. Stadtman Role of oxidant species in aging. , 2004, Current medicinal chemistry.

[19]  R. Dean,et al.  Proteolytic 'defences' and the accumulation of oxidized polypeptides in cataractogenesis and atherogenesis. , 2003, Biochemical Society symposium.

[20]  M. Davies,et al.  Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. , 2003, The Biochemical journal.

[21]  T. Iwaki,et al.  Involvement of cathepsin B in the motor neuron degeneration of amyotrophic lateral sclerosis , 2003, Acta Neuropathologica.

[22]  U. Brunk,et al.  Lipofuscin: mechanisms of age-related accumulation and influence on cell function. , 2002, Free radical biology & medicine.

[23]  R. Dean,et al.  Oxidation of DNA, proteins and lipids by DOPA, protein-bound DOPA, and related catechol(amine)s. , 2002, Toxicology.

[24]  R. Dean,et al.  Biosynthetic incorporation of oxidized amino acids into proteins and their cellular proteolysis. , 2002, Free radical biology & medicine.

[25]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[26]  E. Stadtman,et al.  Protein Oxidation in Aging and Age‐Related Diseases , 2001, Annals of the New York Academy of Sciences.

[27]  R. Dean,et al.  Metabolism of protein-bound DOPA in mammals. , 2000, The international journal of biochemistry & cell biology.

[28]  T. Grune,et al.  Proteasome‐dependent degradation of oxidized proteins in MRC‐5 fibroblasts , 1998, FEBS letters.

[29]  R. Dean,et al.  The Hydroxyl Radical in Lens Nuclear Cataractogenesis* , 1998, The Journal of Biological Chemistry.

[30]  R. Dean,et al.  Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. , 1998, The Biochemical journal.

[31]  R. Dean,et al.  Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins. , 1998, The Biochemical journal.

[32]  E. Nilsson,et al.  Preparation of artificial ceroid/lipofuscin by UV-oxidation of subcellular organelles , 1997, Mechanisms of Ageing and Development.

[33]  J. Longhurst,et al.  Hydroxyl radical production during myocardial ischemia and reperfusion in cats. , 1996, The American journal of physiology.

[34]  T. Reinheckel,et al.  Degradation of Oxidized Proteins in K562 Human Hematopoietic Cells by Proteasome* , 1996, The Journal of Biological Chemistry.

[35]  K. Davies,et al.  Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome. , 1994, Archives of biochemistry and biophysics.

[36]  R. Nixon,et al.  Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease , 1994, Brain Research.

[37]  R. Bolli,et al.  Use of aromatic hydroxylation of phenylalanine to measure production of hydroxyl radicals after myocardial ischemia in vivo. Direct evidence for a pathogenetic role of the hydroxyl radical in myocardial stunning. , 1993, Circulation research.

[38]  K. Davies,et al.  Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex, proteasome. , 1993, The Journal of biological chemistry.

[39]  R. Dean,et al.  Protein-bound 3,4-dihydroxyphenylalanine is a major reductant formed during hydroxyl radical damage to proteins. , 1993, Biochemistry.

[40]  P. Gallop,et al.  Specific detection of quinoproteins by redox-cycling staining. , 1991, The Journal of biological chemistry.

[41]  J. Lunec,et al.  Protein fluorescence and its relationship to free radical activity. , 1987, The British journal of cancer. Supplement.

[42]  W. Garrison REACTION MECHANISMS IN THE RADIOLYSIS OF PEPTIDES, POLYPEPTIDES AND PROTEINS II REACTIONS AT SIDE-CHAIN LOCI IN MODEL SYSTEMS , 1982 .

[43]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Orange,et al.  Functional characterization of rat mast cell arylsulfatase activity. , 1976, Journal of immunology.

[45]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.